Connection

David Taber to Humans

Back to Details
This is a "connection" page, showing publications David Taber has written about Humans.
David Taber
Connection Strength
2.178
Humans
  1. Multilevel Intervention to Improve Racial Equity in Access to Kidney Transplant. J Am Coll Surg. 2023 Apr 01; 236(4):721-727.
    View in: PubMed
    Score: 0.033
  2. Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation. Pharmacogenet Genomics. 2023 04 01; 33(3):59-65.
    View in: PubMed
    Score: 0.033
  3. A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs. Clin Transplant. 2023 03; 37(3):e14876.
    View in: PubMed
    Score: 0.033
  4. A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial. Ann Pharmacother. 2022 06; 56(6):685-690.
    View in: PubMed
    Score: 0.030
  5. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. Am J Transplant. 2021 10; 21(10):3428-3435.
    View in: PubMed
    Score: 0.030
  6. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 07 09; 78(14):1287-1293.
    View in: PubMed
    Score: 0.030
  7. Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 07 01; 156(7):639-645.
    View in: PubMed
    Score: 0.029
  8. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients. Ther Drug Monit. 2021 06 01; 43(3):401-407.
    View in: PubMed
    Score: 0.029
  9. Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):776-784.
    View in: PubMed
    Score: 0.029
  10. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 08; 362(2):130-134.
    View in: PubMed
    Score: 0.029
  11. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy. 2021 01; 41(1):119-131.
    View in: PubMed
    Score: 0.028
  12. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am J Transplant. 2020 08; 20(8):1969-1983.
    View in: PubMed
    Score: 0.027
  13. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. Ann Pharmacother. 2020 12; 54(12):1185-1193.
    View in: PubMed
    Score: 0.027
  14. Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS). Ther Drug Monit. 2020 06; 42(3):415-420.
    View in: PubMed
    Score: 0.027
  15. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clin Transplant. 2020 04; 34(4):e13844.
    View in: PubMed
    Score: 0.027
  16. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.027
  17. Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients. Transplantation. 2019 12; 103(12):2675-2681.
    View in: PubMed
    Score: 0.026
  18. Randomized controlled trial assessing the impact of everolimus and low-exposure tacrolimus on graft outcomes in kidney transplant recipients. Clin Transplant. 2019 10; 33(10):e13679.
    View in: PubMed
    Score: 0.026
  19. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149.
    View in: PubMed
    Score: 0.026
  20. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.025
  21. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682.
    View in: PubMed
    Score: 0.025
  22. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Exp Clin Transplant. 2019 12; 17(6):707-713.
    View in: PubMed
    Score: 0.025
  23. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
    View in: PubMed
    Score: 0.024
  24. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371.
    View in: PubMed
    Score: 0.024
  25. Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population. Ann Pharmacother. 2018 10; 52(10):974-982.
    View in: PubMed
    Score: 0.024
  26. Evolving Trends in Racial Disparities for Peri-Operative Outcomes with the New Kidney Allocation System (KAS) Implementation. J Racial Ethn Health Disparities. 2018 12; 5(6):1171-1179.
    View in: PubMed
    Score: 0.023
  27. Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. Am J Nephrol. 2018; 47(3):191-199.
    View in: PubMed
    Score: 0.023
  28. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128.
    View in: PubMed
    Score: 0.023
  29. Assessment of risk factors for increased resource utilization in kidney transplantation. J Surg Res. 2018 02; 222:195-202.e2.
    View in: PubMed
    Score: 0.023
  30. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
    View in: PubMed
    Score: 0.023
  31. Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients. Surgery. 2018 02; 163(2):430-435.
    View in: PubMed
    Score: 0.023
  32. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.023
  33. Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017 Sep 01; 74(17 Supplement 3):S67-S74.
    View in: PubMed
    Score: 0.023
  34. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.022
  35. Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients. Prog Transplant. 2017 06; 27(2):187-191.
    View in: PubMed
    Score: 0.022
  36. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169.
    View in: PubMed
    Score: 0.022
  37. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
    View in: PubMed
    Score: 0.022
  38. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592.
    View in: PubMed
    Score: 0.022
  39. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139.
    View in: PubMed
    Score: 0.022
  40. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
    View in: PubMed
    Score: 0.021
  41. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
    View in: PubMed
    Score: 0.021
  42. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
    View in: PubMed
    Score: 0.021
  43. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.
    View in: PubMed
    Score: 0.021
  44. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.
    View in: PubMed
    Score: 0.021
  45. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
    View in: PubMed
    Score: 0.021
  46. Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapy. J Am Pharm Assoc (2003). 2016 Jul-Aug; 56(4):450-454.e1.
    View in: PubMed
    Score: 0.021
  47. Depression, Resource Utilization, and Outcomes Following Liver Transplant. Prog Transplant. 2016 Sep; 26(3):270-6.
    View in: PubMed
    Score: 0.021
  48. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.021
  49. Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation? Prog Transplant. 2015 Sep; 25(3):257-62.
    View in: PubMed
    Score: 0.020
  50. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
    View in: PubMed
    Score: 0.019
  51. A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs. Am J Transplant. 2015 Oct; 15(10):2683-90.
    View in: PubMed
    Score: 0.019
  52. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
    View in: PubMed
    Score: 0.019
  53. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg. 2015 Mar; 120(3):619-626.
    View in: PubMed
    Score: 0.019
  54. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30.
    View in: PubMed
    Score: 0.019
  55. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015 Mar; 29(3):222-6.
    View in: PubMed
    Score: 0.019
  56. Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation. J Pharm Pract. 2016 Apr; 29(2):97-102.
    View in: PubMed
    Score: 0.018
  57. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.018
  58. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
    View in: PubMed
    Score: 0.018
  59. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
    View in: PubMed
    Score: 0.018
  60. Lithium dosing equations: are they accurate? Ann Pharmacother. 2014 May; 48(5):596-600.
    View in: PubMed
    Score: 0.018
  61. Association between patient satisfaction and outcomes in kidney transplant. Am J Med Qual. 2015 Mar-Apr; 30(2):180-5.
    View in: PubMed
    Score: 0.018
  62. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97.
    View in: PubMed
    Score: 0.018
  63. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.017
  64. Clinical management strategies and implications for parenteral nutrition drug shortages in adult patients. Pharmacotherapy. 2014 Jan; 34(1):72-84.
    View in: PubMed
    Score: 0.017
  65. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.017
  66. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.016
  67. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.016
  68. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44.
    View in: PubMed
    Score: 0.016
  69. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.016
  70. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.016
  71. Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician. Am J Transplant. 2013 Jan; 13(1):20-30.
    View in: PubMed
    Score: 0.016
  72. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12.
    View in: PubMed
    Score: 0.016
  73. No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech. 2009 Apr; 19(2):153-6.
    View in: PubMed
    Score: 0.013
  74. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.012
  75. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother. 2008 Jan; 42(1):116-20.
    View in: PubMed
    Score: 0.012
  76. Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50.
    View in: PubMed
    Score: 0.011
  77. Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
    View in: PubMed
    Score: 0.010
  78. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.009
  79. Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients. Ther Drug Monit. 2003 Feb; 25(1):67-72.
    View in: PubMed
    Score: 0.008
  80. Incidence and patterns of persistent opioid use in children following appendectomy. J Pediatr Surg. 2022 Dec; 57(12):912-919.
    View in: PubMed
    Score: 0.008
  81. Early Assessment of National Kidney Allocation Policy Change. J Am Coll Surg. 2022 04 01; 234(4):565-570.
    View in: PubMed
    Score: 0.008
  82. Surgical Outcomes Improvement and Health Inequity in a Regional Quality Collaborative. J Am Coll Surg. 2022 04 01; 234(4):607-614.
    View in: PubMed
    Score: 0.008
  83. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. Liver Transpl. 2002 Mar; 8(3):219-23.
    View in: PubMed
    Score: 0.008
  84. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
    View in: PubMed
    Score: 0.008
  85. A Dialysis Center Educational Video Intervention Increases Patient Self-Efficacy and Kidney Transplant Evaluations. Prog Transplant. 2022 03; 32(1):27-34.
    View in: PubMed
    Score: 0.008
  86. Unfractionated and Low-Molecular-Weight Heparin for Bridging Patients with Left Ventricular Assist Device: An Event-Based Analysis. ASAIO J. 2021 12 01; 67(12):1277-1283.
    View in: PubMed
    Score: 0.008
  87. Challenges for expansion of thoracic transplant clinical pharmacy in a developing country: comparison with U.S. accredited centres and call for action. J Clin Pharm Ther. 2022 May; 47(5):588-591.
    View in: PubMed
    Score: 0.008
  88. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2021 10; 16(10):1539-1551.
    View in: PubMed
    Score: 0.008
  89. The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
    View in: PubMed
    Score: 0.007
  90. Non-Adherence to Appointments is a Strong Predictor of Medication Non-Adherence and Outcomes in Kidney Transplant Recipients. Am J Med Sci. 2021 10; 362(4):381-386.
    View in: PubMed
    Score: 0.007
  91. Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation. Transplant Proc. 2021 Jun; 53(5):1665-1669.
    View in: PubMed
    Score: 0.007
  92. Safety and Efficacy of Perioperative Sublingual Tacrolimus in Pancreas Transplant Compared With Oral Tacrolimus. Exp Clin Transplant. 2021 06; 19(6):592-595.
    View in: PubMed
    Score: 0.007
  93. Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636.
    View in: PubMed
    Score: 0.007
  94. Music Therapy in Dialysis Access Procedures With Moderate Sedation. Am Surg. 2022 Jan; 88(1):70-73.
    View in: PubMed
    Score: 0.007
  95. Facilitated Regional Collaboration and In-Hospital Surgical Complication. J Am Coll Surg. 2021 04; 232(4):536-543.
    View in: PubMed
    Score: 0.007
  96. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.007
  97. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13.
    View in: PubMed
    Score: 0.007
  98. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
    View in: PubMed
    Score: 0.007
  99. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
    View in: PubMed
    Score: 0.007
  100. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
    View in: PubMed
    Score: 0.007
  101. Phenotype of immunosuppression reduction after kidney transplantation. Clin Transplant. 2020 10; 34(10):e14047.
    View in: PubMed
    Score: 0.007
  102. Patterns of emergency department utilization between transplant and non-transplant centers and impact on clinical outcomes in kidney recipients. Clin Transplant. 2020 09; 34(9):e13983.
    View in: PubMed
    Score: 0.007
  103. Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. Transplant Proc. 2000 May; 32(3):660-2.
    View in: PubMed
    Score: 0.007
  104. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
    View in: PubMed
    Score: 0.007
  105. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):559-564.
    View in: PubMed
    Score: 0.007
  106. Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort study. Transpl Int. 2020 04; 33(4):414-422.
    View in: PubMed
    Score: 0.007
  107. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.007
  108. Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clin Transplant. 2019 10; 33(10):e13695.
    View in: PubMed
    Score: 0.007
  109. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020 01; 22(1):102-108.
    View in: PubMed
    Score: 0.006
  110. Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease. BMC Nephrol. 2019 07 03; 20(1):241.
    View in: PubMed
    Score: 0.006
  111. Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left?Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778.
    View in: PubMed
    Score: 0.006
  112. Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522.
    View in: PubMed
    Score: 0.006
  113. Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. Exp Clin Transplant. 2019 12; 17(6):796-802.
    View in: PubMed
    Score: 0.006
  114. Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.
    View in: PubMed
    Score: 0.006
  115. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types. Transplantation. 2018 09; 102(9):1440-1452.
    View in: PubMed
    Score: 0.006
  116. Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts. Soc Sci Med. 2018 08; 211:198-206.
    View in: PubMed
    Score: 0.006
  117. Feasibility and Functional Testing for Frailty in Chronic Kidney Disease. Prog Transplant. 2018 09; 28(3):299-300.
    View in: PubMed
    Score: 0.006
  118. The effect of Share 35 on biliary complications: An interrupted time series analysis. Am J Transplant. 2019 01; 19(1):221-226.
    View in: PubMed
    Score: 0.006
  119. Effect of frailty on resource use and cost for Medicare patients. J Comp Eff Res. 2018 08; 7(8):817-825.
    View in: PubMed
    Score: 0.006
  120. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
    View in: PubMed
    Score: 0.006
  121. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.006
  122. Mobile Health in Solid Organ Transplant: The Time Is Now. Am J Transplant. 2017 Sep; 17(9):2263-2276.
    View in: PubMed
    Score: 0.005
  123. Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept. Am J Transplant. 2017 03; 17(3):671-681.
    View in: PubMed
    Score: 0.005
  124. Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors. Prog Transplant. 2016 Dec; 26(4):292-298.
    View in: PubMed
    Score: 0.005
  125. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
    View in: PubMed
    Score: 0.005
  126. Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population? Prog Transplant. 2016 Jun; 26(2):122-8.
    View in: PubMed
    Score: 0.005
  127. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
    View in: PubMed
    Score: 0.005
  128. Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes? Medicine (Baltimore). 2015 Dec; 94(49):e2283.
    View in: PubMed
    Score: 0.005
  129. Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
    View in: PubMed
    Score: 0.005
  130. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
    View in: PubMed
    Score: 0.005
  131. Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23.
    View in: PubMed
    Score: 0.005
  132. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
    View in: PubMed
    Score: 0.005
  133. Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis. J Gastrointest Surg. 2015 Feb; 19(2):282-9.
    View in: PubMed
    Score: 0.005
  134. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.
    View in: PubMed
    Score: 0.005
  135. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
    View in: PubMed
    Score: 0.005
  136. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.004
  137. Building a business plan to support a transplantation pharmacy practice model. Am J Health Syst Pharm. 2014 May 01; 71(9):751-7.
    View in: PubMed
    Score: 0.004
  138. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
    View in: PubMed
    Score: 0.004
  139. Hypertension after kidney transplantation: a pathophysiologic approach. Curr Hypertens Rep. 2013 Oct; 15(5):458-69.
    View in: PubMed
    Score: 0.004
  140. Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation. Transpl Infect Dis. 2013 Dec; 15(6):551-8.
    View in: PubMed
    Score: 0.004
  141. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013 Sep-Oct; 27(5):732-41.
    View in: PubMed
    Score: 0.004
  142. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013 May; 33(5):483-8.
    View in: PubMed
    Score: 0.004
  143. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8.
    View in: PubMed
    Score: 0.004
  144. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801.
    View in: PubMed
    Score: 0.004
  145. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res. 2013 Jan 08; 15(1):e6.
    View in: PubMed
    Score: 0.004
  146. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Am J Health Syst Pharm. 2012 Nov 15; 69(22):1993-8.
    View in: PubMed
    Score: 0.004
  147. Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer. 2013 May; 14(3):224-9.
    View in: PubMed
    Score: 0.004
  148. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):330-4.
    View in: PubMed
    Score: 0.004
  149. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View in: PubMed
    Score: 0.004
  150. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Transplant Proc. 2012 Jun; 44(5):1323-8.
    View in: PubMed
    Score: 0.004
  151. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7.
    View in: PubMed
    Score: 0.004
  152. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.004
  153. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant. 2011 Aug; 11(8):1576-83.
    View in: PubMed
    Score: 0.004
  154. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
    View in: PubMed
    Score: 0.003
  155. Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies. Ann Pharmacother. 2010 Jul-Aug; 44(7-8):1259-70.
    View in: PubMed
    Score: 0.003
  156. Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? Transplantation. 2010 May 27; 89(10):1218-23.
    View in: PubMed
    Score: 0.003
  157. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7.
    View in: PubMed
    Score: 0.003
  158. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
    View in: PubMed
    Score: 0.003
  159. Implementation of a collaborative drug therapy management service for inpatients receiving direct thrombin inhibitors. Am J Health Syst Pharm. 2009 Jul 15; 66(14):1297-303.
    View in: PubMed
    Score: 0.003
  160. The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series. Transpl Infect Dis. 2009 Jun; 11(3):269-76.
    View in: PubMed
    Score: 0.003
  161. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.003
  162. Gefitinib plus celecoxib in chemotherapy-na?ve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group. J Thorac Oncol. 2008 Apr; 3(4):374-9.
    View in: PubMed
    Score: 0.003
  163. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer. Cancer Chemother Pharmacol. 2005 Oct; 56(4):421-6.
    View in: PubMed
    Score: 0.002
  164. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22.
    View in: PubMed
    Score: 0.002
  165. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May; 36(4):1048-9.
    View in: PubMed
    Score: 0.002
  166. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1058-60.
    View in: PubMed
    Score: 0.002
  167. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
    View in: PubMed
    Score: 0.002
  168. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg. 2001 Dec; 136(12):1433-5.
    View in: PubMed
    Score: 0.002
  169. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol. 2000 Jan; 18(2):371-5.
    View in: PubMed
    Score: 0.002
  170. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. Clin Cancer Res. 1998 Apr; 4(4):929-34.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.